The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents (POPVAC C): an open-label, randomised controlled trial
Alliance for Accelerating Excellence in Science in Africa
European and Developing Countries Clinical Trials Partnership
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents (POPVAC C): an open-label, randomised controlled trial
Pontiano Kaleebu, Caroline Onen, Paul L. A. M. Corstjens, Emily L. Webb et al.
Citations
3 citations
Journal
The Lancet Global Health
Topics
Immune responses and vaccinations
Field-Weighted Citation Impact (FWCI)
0.72
article
The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents (POPVAC C): an open-label, randomised controlled trial
Pontiano Kaleebu, Caroline Onen, Paul L. A. M. Corstjens, Emily L. Webb, Gyaviira Nkurunungi, Rebecca Amongin, John Kayiwa, Susan Amongi, Christopher Zziwa, Govert J. van Dam, Denis Nsubuga, Agnes Natukunda, Alison M. Elliott, Barbara Apule, Caroline Ninsiima, Stephen Cose, Anne Wajja, Ludoviko Zirimenya, Jacent Nassuuna, Pius Tumwesige, Joel Serubanja, Joyce Kabagenyi
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Global HealthVol. 12(11)
Institutions
Leiden University Medical Center (NL), London School of Hygiene & Tropical Medicine (GB), Uganda Virus Research Institute (UG)
Funders
London School of Hygiene and Tropical Medicine, Wellcome Trust, Frederick National Laboratory for Cancer Research, Government of the United Kingdom, UK Research and Innovation, National Institute for Health and Care Research, Universiteit Leiden, Leids Universitair Medisch Centrum, New Partnership for Africa's Development, African Academy of Sciences, Foreign, Commonwealth and Development Office, Medical Research Council, Alliance for Accelerating Excellence in Science in Africa, European and Developing Countries Clinical Trials Partnership